Ensoma, founded in 2019, is a biotechnology company with the goal of expanding the reach of the curative power of genomic medicine by seeking to pioneer a next-generation in vivo approach using its Engenious vectors. Ensoma’s vectors are designed to deliver a diverse range of gene modification technologies without the need for stem cell collection or prior myeloablative conditioning (e.g., chemotherapy). As a result, Ensoma’s therapies aim to be delivered as a single injection in a diverse range of settings, including outpatient and settings where access to sophisticated healthcare systems may be limited. Ensoma is headquartered in Boston, Massachusetts.

Register for Details

For more details on financing and valuation for Ensoma, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Ensoma

Forge green plus iconForge green minus icon

What is Ensoma's IPO price?

The IPO price for Ensoma will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Ensoma?

Ensoma is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Ensoma shares pre-IPO?

If you own Ensoma pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Ensoma a publicly traded company?

Ensoma is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Ensoma's funding to date?

Ensoma has raised $163.05MM to date.
Forge green plus iconForge green minus icon

When was Ensoma founded?

Ensoma was founded in 2019.

Who are Ensoma's major investors?

Viking Global Investors
Takeda Ventures
Bill & Melinda Gates Foundation
RIT Capital Partners
F-Prime Capital
Qatar Investment Authority
Mirae Asset Global Investments
Cormorant Asset Management
Delos Capital
Catalio Capital Management
SymBiosis Capital Management
Arix Bioscience
Bioluminescence Ventures
Gilead Sciences
Solasta Ventures
5AM Ventures
Alexandria Venture Investments
Fred Hutchinson Cancer Research Center
Kite Pharma

Ensoma Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
4/13/2023 Series B $92.5MM raised $XXX.XX $XXX.XX
2/11/2021 Series A and A-1 $70.55MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Jun 14, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.